Regenerative Medicine Market 2030: Pioneering the Future of Healing
Regenerative Medicine Market Summary The global regenerative medicine market was valued at USD 35.47 billion in 2024 and is expected to reach USD 90.01 billion by 2030, expanding at a CAGR of 16.83% from 2025 to 2030. Ongoing advancements in biological therapies have driven a shift toward personalized medical approaches, creating strong growth opportunities for companies developing biologic therapeutics. The rising prevalence of degenerative diseases has heightened the need for research aimed at identifying innovative regenerative treatments. The COVID-19 pandemic also influenced the field significantly, disrupting regenerative medicine and T-cell therapy manufacturing. The widespread impact of SARS-CoV-2 affected not only patient care but also administration, logistics, and clinical research operations. Numerous institutions temporarily slowed clinical trial enrollments and related research. Despite these challenges, the market remains on an upward trajectory as industry players su...